RESEARCH PROGRESS OF DUB ENZYME IN HEPATOCELLULAR CARCINOMA

Research Progress of DUB Enzyme in Hepatocellular Carcinoma

According to GLOBOCAN 2021 cancer incidence and mortality statistics compiled by the International Agency for Research on Cancer, hepatocellular carcinoma (HCC) is the most common malignancy in the human liver and one of the leading causes of cancer death worldwide.Although there have been great advances in the treatment of HCC, such as regofenib,

read more



Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes

Abstract Background Myelodysplastic syndromes (MDS) are a group of heterogeneous myeloid clonal disorders characterized by ineffective haematopoiesis and immune deregulation.Emerging evidence has shown the effect of bone marrow (BM) outer banks pura vida endothelial progenitor cells (EPCs) in regulating haematopoiesis and immune balance.However, th

read more

Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.

BACKGROUND:Both procalcitonin (PCT) and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) have been investigated separately as indicators of infection in patients with autoimmune diseases.Our study simultaneously evaluated both PCT and sTREM-1 along with C-reactive protein (CRP) in febrile patients with autoimmune diseases.METHODS:

read more